Optimizing Treatment in Patients with ROS1 Rearranged NSCLC

Annenberg Center for Health Sciences
  • 0.0 (0)
  • Medicine

Greater understanding and implementation of molecular biomarkers in non-small cell lung cancer (NSCLC) have led to improved patient outcomes. However, optimizing therapeutic strategies for patients with a molecular alteration continues to be challenging for the multidisciplinary team. Among these alterations, ROS1 rearrangements are rare, but have important clinical implications.

Episodes

  1. 10/07/2024

    Introduction and Key Takeaways

    This full educational program can be accessed at no cost here: https://annenberg.net/courses/landingPage.php?courseID=61030

    15 min
  • 1 Episode

About

Greater understanding and implementation of molecular biomarkers in non-small cell lung cancer (NSCLC) have led to improved patient outcomes. However, optimizing therapeutic strategies for patients with a molecular alteration continues to be challenging for the multidisciplinary team. Among these alterations, ROS1 rearrangements are rare, but have important clinical implications.

Information